What is Akesis?
Akesis is dedicated to making life-saving radiation medicine accessible to all. The company is developing cutting-edge stereotactic radiosurgery and linear accelerator platforms that feature patented, continuous 360-degree rotational technology coupled with real-time, in-line imaging. By integrating advanced technology with established treatment methodologies, Akesis aims to redefine the landscape of Radiation Medicine. Its products are manufactured in the United States at a facility located outside San Francisco, California.
How much funding has Akesis raised?
Akesis has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in Akesis
PPP
Public-Private Partnership
What's next for Akesis?
With a recent strategic investment and substantial total funding, Akesis is poised for significant growth and market penetration. The company's focus on innovative technology, particularly its continuous rotational and real-time imaging capabilities, suggests a strategic push towards enhancing treatment precision and patient outcomes in radiation oncology. This late-stage funding likely supports scaling manufacturing operations, expanding clinical trials, and accelerating commercialization efforts for its Galaxy RTi and Gemini360 platforms, aiming to capture a larger share of the radiation therapy market.
See full Akesis company page
